In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 69 for your search:
Drug:  tegafur-gimeracil-oteracil potassium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 20 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 01023010 / TOP-003, NCT00284258

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: JACCRO GC-05, NCT00639327

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: KYUH-UHA-GC04-03, NCT00182611

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 75
Sponsor: Other
Protocol IDs: JCOG9912, C000000062, NCT00142350

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: HKIT-GC, NCT00216034

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SC101, NCT00202969

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 77
Sponsor: Pharmaceutical / Industry
Protocol IDs: ISO/5FU-10, NCT00195572

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 79
Sponsor: Other
Protocol IDs: JACCRO GC-03, NCT00287768

9.

Phase: Phase III
Type: Treatment
Status: Temporarily closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: HGCSG0601, IFOX study, NCT00316745

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor: Other
Protocol IDs: YCU-BRI-HN-05-01, NCT00336947

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 01023017, NCT00498225

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000593164, TMDU-TRICC0706, TRICC0706, NCT00660894

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-03-012, NCT00677443

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: TMOG-GC01, NCT00687843

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10020380, NCT00770874

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: 2009-0056, NCT00869635

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TPU S-1301, TAIHO-TPU-S1301, QUINT-TPU-S1301, NCT00400179

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 74
Sponsor: Other
Protocol IDs: SOS, NCT00915382

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: TPU-S1303, NCT01285557

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: Fudan BR2012-09 CBCSG010, NCT01655992

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TPU-S1101; ID02-694, NCT00072787

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 76 to 80
Sponsor: Other
Protocol IDs: HGCSG0502, DS-Elderly, NCT00209729

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 20 to 75
Sponsor: Other
Protocol IDs: HGCSG0405, GEMS-1, NCT00209677

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 to 74
Sponsor: Other
Protocol IDs: SCC-07-01, NCT00524706

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2006-01-024, NCT00531245
1    
New Search